Scarica l'app Stockscreener
0.0201
85.48%
-0.1184
Dopo l'orario di chiusura:
.02
-0.000100
-0.50%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TTOO Giù?
Forum
Previsione
Frazionamento azionario
T 2 Biosystems Inc Borsa (TTOO) Ultime notizie
Head to Head Survey: Presbia (OTCMKTS:LENSF) & T2 Biosystems (NASDAQ:TTOO) - Defense World
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - GlobeNewswire Inc.
TTOO SEC FilingsT2 Biosystems 10-K, 10-Q, 8-K Forms - Stock Titan
Investor Network: T2 Biosystems, Inc. to Host Earnings Call - ACCESS Newswire
Emerging Lyme Disease Diagnostics Market Opportunities - openPR.com
North American Morning Briefing: Stock Futures Down, Earnings Expectations, and Analyst Ratings Actions - AInvest
T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Above 50-Day Moving Average – Should You Sell? - Defense World
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Wall Street Zen Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200 Day Moving Average – Should You Sell? - Defense World
StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - The AM Reporter
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200-Day Moving Average – Time to Sell? - The AM Reporter
T2 Biosystems Delays Yearly Report Filing - TipRanks
Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider - Yahoo Finance
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com - The AM Reporter
T2 Biosystems, Inc. to Host Earnings Call - ACCESS Newswire
Blood Culture Screening Devices Market Rewriting its Growth Cycle | bioMérieux SA, OpGen, T2 Biosystems - Newstrail
T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com - Defense World
T2 Biosystems Announces Major Reduction-In-Force and Plans for Potential Sale - Defense World
T2 Biosystems initiates major layoffs, seeks asset sale By Investing.com - Investing.com Australia
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com India
Massachusetts-based medical diagnostics firm lays off ‘substantially all' employees - NBC Boston
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems, Inc. Revenue Breakdown – OTC:TTOO - TradingView
T2 Biosystems to be delisted from Nasdaq - MSN
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results - br.ADVFN.com
T2 Biosystems stock plunges to 52-week low of $0.22 - MSN
T2 Biosystems to be delisted from Nasdaq By Investing.com - Investing.com Canada
T2 Biosystems Gets Nasdaq Delisting Notice; Shares Down - marketscreener.com
Navigating TTOO’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
T2 Biosystems Receives Delisting Notice from Nasdaq, Plans to Move to OTC MarketsLEXINGTON, Massachusetts–(BUSINESS WIRE)–T2 Biosystems, Inc. (NASDAQ: TTOO) announced today that it has received notice from the Nasdaq Stock Market LLC (“Na - Defense World
Analyzing Ratios: T2 Biosystems Inc (TTOO)’s Financial Story Unveiled - The Dwinnex
2.04%
1.25%
Capitalizzazione:
|
Volume (24 ore):